NuVasive's Q2 revenue rises 5.3%: 4 notes

Carly Behm -  

NuVasive saw year-over-year increase in second-quarter revenue with $310.5 million, according to financial results posted Aug. 3.

Four things to know:

1. Net sales of $310.5 million is a 5.3 percent jump compared to the same time last year.

2. Second-quarter sales were driven by the 2021 commercial launches of the Simplify cervical disc replacement, Pulse platform and high U.S. procedure volume.

3. Gross profit was $224.7 million, compared to $216.5 million in the same time last year.

4. CEO Chris Barry said: "We are encouraged by our top-line growth in the second quarter, driven by procedure volumes, new product introductions, and continued global execution of our growth strategies. As surgeons look for differentiated technologies to enable more intelligent surgery, our C360 portfolio, X360 portfolio and Pulse platform will continue to support our innovation strategy."

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

Featured Webinars

Featured Podcast

Featured Whitepapers